Explore more publications!

Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

Press releases published on January 8, 2026

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
Cellectis Announces 2026 Strategy and Catalysts
Cellectis annonce sa stratégie et ses jalons attendus en 2026
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
Syneos Health Appoints Simon Bartle as Chief Human Resources Officer
Informe de BitMEX halla que los perpetuos cripto entran en la era posterior al rendimiento
Halmblog Music Partners with 1,000+ Independent Artists to Rewrite Africa’s Music Story
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
Surface Sampling at Smart Creek Project Yields High-Grade Mineralization with up to 102 g/t Au, up to 23% Cu and up to 3810 g/t Ag
Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases
Synfini Opens Cloud Access to its Agile AI Foundry to Accelerate Discovery of Better Molecules
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones
Alkeus Pharmaceuticals to Present Corporate Update at the 44th Annual J.P. Morgan Healthcare Conference
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions